These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22105595)

  • 1. Minimization of the preanalytical error in plasma samples for pharmacokinetic analyses and therapeutic drug monitoring--using doxorubicin as an example.
    Kontny NE; Hempel G; Boos J; Boddy AV; Krischke M
    Ther Drug Monit; 2011 Dec; 33(6):766-71. PubMed ID: 22105595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reliable and safe method of collecting blood samples from implantable central venous catheters for determination of plasma gentamicin concentrations.
    Chen J; Boodhan S; Nanji M; Chang A; Sekharan S; Lavoratore S; Brandão LR; Skolnik JM; Dupuis LL
    Pharmacotherapy; 2011 Aug; 31(8):776-84. PubMed ID: 21923604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A limited sampling strategy for the study of pirarubicin pharmacokinetics in humans.
    Marchiset-Leca D; Leca FR; Galeani A; Noble A; Iliadis A
    Cancer Chemother Pharmacol; 1995; 36(3):233-8. PubMed ID: 7781144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic drug monitoring of doxorubicin in paediatric oncology using capillary electrophoresis.
    Hempel G; Schulze-Westhoff P; Flege S; Laubrock N; Boos J
    Electrophoresis; 1998 Nov; 19(16-17):2939-43. PubMed ID: 9870393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple HPLC method for doxorubicin in plasma and tissues of nude mice.
    Al-Abd AM; Kim NH; Song SC; Lee SJ; Kuh HJ
    Arch Pharm Res; 2009 Apr; 32(4):605-11. PubMed ID: 19407979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of PT and aPTT values drawn by venipuncture and arterial line using three discard volumes.
    Konopad E; Grace M; Johnston R; Noseworthy T; Shustack A
    Am J Crit Care; 1992 Nov; 1(3):94-101. PubMed ID: 1307912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimization of the preanalytical error in pharmacokinetic analyses and therapeutic drug monitoring: focus on IV drug administration.
    Kontny NE; Boos J; Würthwein G; Hempel G; Boddy AV; Groll AH; Krischke M
    Ther Drug Monit; 2012 Aug; 34(4):460-6. PubMed ID: 22660605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study to determine the minimum volume of blood necessary to be discarded from a central venous catheter before a valid sample is obtained in children with cancer.
    Cole M; Price L; Parry A; Picton S; Waters F; Marshall S; Goran C; Parnham A; Wastell H; Reid MM; Pearson AD; Boddy AV; Veal GJ
    Pediatr Blood Cancer; 2007 Jun; 48(7):687-95. PubMed ID: 16676305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A discard volume of twice the deadspace ensures clinically accurate arterial blood gases and electrolytes and prevents unnecessary blood loss.
    Rickard CM; Couchman BA; Schmidt SJ; Dank A; Purdie DM
    Crit Care Med; 2003 Jun; 31(6):1654-8. PubMed ID: 12794400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obtaining blood samples for coagulation studies from a normal saline lock.
    Powers JM
    Am J Crit Care; 1999 Jul; 8(4):250-3. PubMed ID: 10392225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a limited-sampling model for prediction of doxorubicin exposure in dogs.
    Wittenburg LA; Thamm DH; Gustafson DL
    Vet Comp Oncol; 2014 Jun; 12(2):114-9. PubMed ID: 22747489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic evaluation of doxorubicin plasma levels in normal and overweight patients with breast cancer and simulation of dose adjustment by different indexes of body mass.
    Barpe DR; Rosa DD; Froehlich PE
    Eur J Pharm Sci; 2010 Nov; 41(3-4):458-63. PubMed ID: 20688160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors.
    Tranchand B; Catimel G; Lucas C; Sarkany M; Bastian G; Evene E; Guastalla JP; Négrier S; Rebattu P; Dumortier A; Foy M; Grossin F; Mazier B; Froudarakis M; Barbet N; Clavel M; Ardiet C
    Cancer Chemother Pharmacol; 1998; 41(4):281-91. PubMed ID: 9488597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmafiltration as a possible contributor to kinetic targeting of pegylated liposomal doxorubicin (PLD) in order to prevent organ toxicity and immunosuppression.
    Martínková J; Bláha M; Kubeček O; Maláková J; Špaček J; Bezouška J; Krulichová IS; Filip S
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):429-37. PubMed ID: 26678853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic drug monitoring of methotrexate on the pediatric oncology ward: can blood sampling from central venous accesses substitute for capillary finger punctures?
    Ritzmo C; Albertioni F; Cosic K; Söderhäll S; Eksborg S
    Ther Drug Monit; 2007 Aug; 29(4):447-51. PubMed ID: 17667799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of adriamycin by bronchial artery infusion for non-small cell bronchogenic carcinoma].
    Wang T; Yang H; Wang H
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):395-8. PubMed ID: 11810771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discard volumes necessary for clinically useful coagulation studies from heparinized Hickman catheters.
    Mayo DJ; Dimond EP; Kramer W; Horne MK
    Oncol Nurs Forum; 1996 May; 23(4):671-5. PubMed ID: 8735325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved HPLC method for doxorubicin quantification in rat plasma to study the pharmacokinetics of micelle-encapsulated and liposome-encapsulated doxorubicin formulations.
    Wei G; Xiao S; Si D; Liu C
    Biomed Chromatogr; 2008 Nov; 22(11):1252-8. PubMed ID: 18651589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lattice intrahepatic doxorubicin with and without in-flow occlusion: a pharmacokinetic study of direct liver injection.
    Averbach A; Stuart OA; Chang D; Sugarbaker PH
    Eur J Surg Oncol; 2000 Feb; 26(1):73-9. PubMed ID: 10718184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.